BCL2L1 and pancreatic neoplasm: Similarly, the antiapoptotic BCL2L1 gene, which was found downregulated in sporaminin-induced apoptotic pancreatic cancer cells [97] (Table 1), is overexpressed in pancreatic adenocarcinoma (Table 2).